Literature DB >> 8709240

Amino acids essential for RNase H activity of hepadnaviruses are also required for efficient elongation of minus-strand viral DNA.

Y Chen1, P L Marion.   

Abstract

The hepadnavirus P gene contains amino acid sequences which share homology with all known RNases H. In this study, we made four mutants in which single amino acids of the duck hepatitis B virus (DHBV) RNase H region were altered. In two of them, amino acids at locations comprising the putative catalytic site were changed, while the remaining mutants had alterations at amino acids conserved among hepadnaviruses. Transfection of these mutant genomes into permissive cells resulted in synthesis of several discrete viral nucleic acid species, ranging in apparent sizes from approximately 500 to 3,000 bp, numbered I, II, III, IV, and V. While the locations of the species were similar in all mutants, the proportions of the species varied among the mutants. Analysis of the nucleic acid species revealed that they were hybrid molecules of RNA and minus-strand DNA, indicating that the RNase H activity was missing or greatly reduced in these mutants. Primer extension experiments showed that the mutant viruses initiated minus-strand viral DNA synthesis normally. The 3' termini of minus-strand DNA in species II, III, and IV were mapped just downstream of nucleotides 1659, 1220, and 721, respectively. Species V contained essentially full-length minus-strand viral DNA. A parallel amino acid change in the putative catalytic site of the HBV RNase H domain resulted in accumulation of low-molecular-weight hybrid molecules consisting of RNA and minus-strand DNA and similar in size and pattern to those seen with DHBV. These studies demonstrate experimentally the involvement of the C-terminal portion of the P gene in RNase H activity in both DHBV and human hepatitis B virus and indicate that the amino acids essential for RNase H activity of hepadnavirus P protein are also important for the efficient elongation of minus-strand viral DNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709240      PMCID: PMC190638          DOI: 10.1128/JVI.70.9.6151-6156.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

2.  Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase.

Authors:  L J Chang; R C Hirsch; D Ganem; H E Varmus
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase.

Authors:  J F Davies; Z Hostomska; Z Hostomsky; S R Jordan; D A Matthews
Journal:  Science       Date:  1991-04-05       Impact factor: 47.728

4.  Pregenomic RNA encapsidation analysis of eleven missense and nonsense polymerase mutants of human hepatitis B virus.

Authors:  S Roychoudhury; A F Faruqi; C Shih
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function.

Authors:  N Tanese; A Telesnitsky; S P Goff
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity.

Authors:  G Radziwill; W Tucker; H Schaller
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation.

Authors:  R Bartenschlager; M Junker-Niepmann; H Schaller
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Three-dimensional structure of ribonuclease H from E. coli.

Authors:  K Katayanagi; M Miyagawa; M Matsushima; M Ishikawa; S Kanaya; M Ikehara; T Matsuzaki; K Morikawa
Journal:  Nature       Date:  1990-09-20       Impact factor: 49.962

9.  Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein.

Authors:  W Yang; W A Hendrickson; R J Crouch; Y Satow
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

10.  Naturally occurring point mutation in the C terminus of the polymerase gene prevents duck hepatitis B virus RNA packaging.

Authors:  Y Chen; W S Robinson; P L Marion
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more
  23 in total

1.  Expression of RNase H of human hepatitis B virus polymerase in Escherichia coli.

Authors:  Hong Cheng; Hui-Zhong Zhang; Wan-An Shen; Yan-Fang Liu; Fu-Cheng Ma
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

2.  Base pairing between the 5' half of epsilon and a cis-acting sequence, phi, makes a contribution to the synthesis of minus-strand DNA for human hepatitis B virus.

Authors:  Teresa M Abraham; Daniel D Loeb
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation.

Authors:  Suresh H Basagoudanavar; David H Perlman; Jianming Hu
Journal:  J Virol       Date:  2006-11-29       Impact factor: 5.103

4.  Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction.

Authors:  R E Lanford; Y H Kim; H Lee; L Notvall; B Beames
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 5.  Hepadnavirus Genome Replication and Persistence.

Authors:  Jianming Hu; Christoph Seeger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

6.  Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors.

Authors:  Pinghu Zhang; Fei Liu; Fang Guo; Qiong Zhao; Jinhong Chang; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2016-04-12       Impact factor: 5.970

7.  Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors.

Authors:  Juan Antonio Villa; Daniel P Pike; Kunjan B Patel; Elena Lomonosova; Gaofeng Lu; Roz Abdulqader; John E Tavis
Journal:  Antiviral Res       Date:  2016-06-17       Impact factor: 5.970

8.  Reconstitution of a functional duck hepatitis B virus replication initiation complex from separate reverse transcriptase domains expressed in Escherichia coli.

Authors:  J Beck; M Nassal
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

9.  A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Authors:  Bruno B Bordier; Patricia L Marion; Kazuo Ohashi; Mark A Kay; Harry B Greenberg; John L Casey; Jeffrey S Glenn
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors.

Authors:  Gaofeng Lu; Juan Antonio Villa; Maureen J Donlin; Tiffany C Edwards; Xiaohong Cheng; Richard F Heier; Marvin J Meyers; John E Tavis
Journal:  Antiviral Res       Date:  2016-09-28       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.